Fortier, Michelle |
University Of California-Irvine
United States |
Innovative Pain and Symptom Management Program for Children with Cancer |
3R01CA222012-05S1 |
|
Alexis Bakos, Ph.D., M.P.H., R.N. |
Friday, Bret E.B. |
Essentia Institute Of Rural Health
United States |
Essentia Health Community Cancer Research Program - NCORP |
5UG1CA189812-09 |
|
Worta McCaskill-Stevens, M.D., M.S. |
Geisler, Stefanie |
Washington University
United States |
Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy |
5R37CA267905-02 |
PAR-19-325 (R01 Clinical Trial Optional) |
Alexis Bakos, Ph.D., M.P.H., R.N. |
Geisler, Stefanie |
Washington University
United States |
Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy |
5R37CA267905-02 |
PAR-19-325 (R01 Clinical Trial Optional) |
Alexis Bakos, Ph.D., M.P.H., R.N. |
George, Suzanne |
Alliance Nctn Foundation
United States |
Alliance NCORP Research Base |
3UG1CA189823-09S1 |
|
Worta McCaskill-Stevens, M.D., M.S. |
Gewandter, Jennifer |
University Of Rochester
United States |
Wireless transcutaneous electrical stimulation (TENS) for chemotherapy-induced peripheral neuropathy: A phase II randomized clinical trial |
5R21CA235389-02 |
|
Marge Good, R.N., M.P.H., O.C.N. |
Ghamande, Sharad A. |
Augusta University
United States |
Georgia CaRes |
5UG1CA189851-09 |
|
Worta McCaskill-Stevens, M.D., M.S. |
Golden, Carla B |
Bay Area Tumor Institute
United States |
Bay Area Tumor Institute NCI Community Oncology Research Program (NCORP) Community Sites |
5UG1CA189817-09 |
|
Worta McCaskill-Stevens, M.D., M.S. |
Goode, Diana J |
University Of New England
United States |
Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy |
1R01CA267554-01A1 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Alexis Bakos, Ph.D., M.P.H., R.N. |
Grace, Peter M |
University Of Tx Md Anderson Can Ctr
United States |
PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain |
5R01CA227064-05 |
|
Diane St Germain, R.N., M.S., C.R.N.P. |